Scrip World Pharmaceutical News

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Scrip World Pharmaceutical News
Scrip World Pharmaceutical Logo.png
Type News and analysis service
Format Daily online
Owner(s) Informa plc (LSE: INF)
Publisher Philip Jarvis
Editor Mike Ward
Founded March 1972
Headquarters Telephone House
69-77 Paul St

Scrip Intelligence (Scrip) is an English language international pharmaceutical news, analysis and data service. First published as a weekly print newsletter in March 1972, Scrip included articles on side-effects, regulatory changes and mergers and acquisitions. Scrip has now developed into an online global pharma news and analysis service. It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials.

Scrip is part of Informa.[1]

Scrip subscriber base[edit]

The Scrip readership has grown to over 100,000 worldwide,[2] half of which are in Europe. Scrip is read by managers and executives working across all disciplines in pharmaceutical and biotech companies worldwide.[3]


  • Barbara Obstoj (1972–76)
  • Philip Brown (1977–86)
  • Moira Dower (1986–96)
  • John Davis (1997-2007)
  • Alex Shimmings (2007-2010)
  • Mike Ward (2010–present)

Scrip editorial team[edit]

Scrip has a large independent editorial team of 21. The journalists are based throughout the world in Washington, D.C., Tokyo, India, and London to ensure a global emphasis to the latest news stories.

  • "Science desk" - The R&D section tracks the fortune of marketed and developmental drugs, from clinical data to their passage through the regulatory process.[4][5]
  • "Europe coverage" - Scrip's Europe based desk covers all the political and regulatory developments that affect the pharmaceutical industry in the 27 member states, other European countries and the Russian Federation.
  • "US coverage" - Scrip's US team details the political developments from Washington affecting the global pharma industry, such as U.S. Food and Drug Administration safety and regulatory matters, as well as litigation, Generics and pharmacy.[6]
  • "World coverage" - Scrip's locally based world coverage focuses on Japan and other Pacific Rim markets, Asia and Latin America.
  • "Business news" - Scrip's global reporters bring information on financial and business affairs in the pharma and biotech sectors.[7]
  • "Analyst team" - Scrip's analysts offer an insight into the industry's more significant developments.[8]


  1. ^ "Informa's global locations". Retrieved 2006-01-01. 
  2. ^ "Scrip's readership reaches over 100,000". Retrieved 2008-08-04. 
  3. ^ "Scrip's readers are global mid-senior level management". Retrieved 2008-08-04. 
  4. ^ "Research and development news". Retrieved 2008-08-04. 
  5. ^ "Clinical trials news". Retrieved 2008-08-04. 
  6. ^ "Policy and regulation news". Retrieved 2008-08-04. 
  7. ^ "Financial news". Retrieved 2008-08-04. 
  8. ^ "Scrip's analysis team". Retrieved 2008-08-04. 

External links[edit]